Document detail
ID

doi:10.1186/s13000-023-01346-4...

Author
Karabachev, Alexander D. Brundage, William J. Sajisevi, Mirabelle B. Ciolino, Allison L.
Langue
en
Editor

BioMed Central

Category

Medicine & Public Health

Year

2023

listing date

5/24/2023

Keywords
pathology thyroid cancer-clinical thyroid lymphoma fine needle aspiration cell block diagnosis aspiration biopsy ptl underwent patient fine thyroid diagnosis
Metrics

Abstract

Background Primary thyroid lymphoma (PTL) is a rare cancer accounting for approximately 5% of thyroid malignancies.

Historically, incisional biopsy has been the gold standard for definitive diagnosis of PTL, however, the use of cell block as an adjunct to fine needle aspiration (FNA) provides a high sensitivity and specificity for diagnosis and classification.

Methods Three patients presented with a symptomatic enlarging thyroid mass.

Patient 1 underwent incisional biopsy under general anesthesia, Patient 2 underwent core needle biopsy to avoid high risk intubation, and Patient 3 underwent fine needle aspiration alone with the use of cell block.

Results All patients were diagnosed with a fully classified non-Hodgkin’s lymphoma using immunohistochemistry, flow cytometry, and fluorescence in situ hybridization (FISH) analysis.

Conclusions FNA for diagnosis of some subtypes of PTL is feasible and preferred in cases that are particularly high risk for general anesthesia.

This minimally invasive technique is safe and cost effective as it avoids expenses associated with operative intervention.

Karabachev, Alexander D.,Brundage, William J.,Sajisevi, Mirabelle B.,Ciolino, Allison L., 2023, Feasibility of fine needle aspiration for diagnosis of b-cell lymphoma of the thyroid: a case series and review of the literature, BioMed Central

Document

Open

Share

Source

Articles recommended by ES/IODE AI

A rare case of localized peliosis hepatis during adjuvant chemotherapy including oxaliplatin mimicking a liver metastasis of colon cancer
peliosis hepatis metastatic liver tumor oxaliplatin oxaliplatin associated cancer metastatic tumor liver hepatis peliosis